Trials / Unknown
UnknownNCT03513874
Metformin Plus Insulin on Non-obese Autoimmune Diabetes
The Effect of Metformin as add-on to Insulin in Non-obese Patients With Autoimmune Diabetes
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Second Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the therapeutic effect of metformin as additional treatment with insulin on non-obese autoimmune diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Patients will be subscribed with 850mg metformin orally twice daily. Insulin will be continued as routine therapy. |
| DRUG | Insulin | Patients will continue insulin therapy following physicians' instructions. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2020-12-31
- Completion
- 2021-04-01
- First posted
- 2018-05-02
- Last updated
- 2020-03-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03513874. Inclusion in this directory is not an endorsement.